Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0132 | 0.7513 | 0.7478 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.1964 | 0.5 |
Loa Loa (eye worm) | norepinephrine transporter | 0.0149 | 0.8802 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0059 | 0.1964 | 0.185 |
Echinococcus multilocularis | serotonin transporter | 0.0149 | 0.8802 | 0.8785 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0149 | 0.8802 | 1 |
Echinococcus multilocularis | geminin | 0.0165 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0149 | 0.8802 | 1 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0149 | 0.8802 | 0.5 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0149 | 0.8802 | 0.8802 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0048 | 0.1163 | 0.1321 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0059 | 0.1964 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.1964 | 0.5 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0122 | 0.6768 | 0.6722 |
Loa Loa (eye worm) | hypothetical protein | 0.0149 | 0.8802 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.014 | 0.014 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0059 | 0.1964 | 0.5 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0059 | 0.1964 | 0.185 |
Loa Loa (eye worm) | serotonin transporter b | 0.0149 | 0.8802 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.014 | 0.014 |
Schistosoma mansoni | hypothetical protein | 0.0165 | 1 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.0132 | 0.7513 | 0.7513 |
Brugia malayi | hypothetical protein | 0.0035 | 0.014 | 0.0159 |
Schistosoma mansoni | hypothetical protein | 0.0165 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0149 | 0.8802 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.014 | 0.5 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0122 | 0.6768 | 0.6722 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.014 | 0.5 |
Onchocerca volvulus | 0.0149 | 0.8802 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.1163 | 0.1321 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0149 | 0.8802 | 0.8802 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0059 | 0.1964 | 0.1964 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0048 | 0.1163 | 0.1321 |
Echinococcus granulosus | serotonin transporter | 0.0149 | 0.8802 | 0.8785 |
Schistosoma mansoni | thyroid hormone receptor | 0.0132 | 0.7513 | 0.7513 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0149 | 0.8802 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0048 | 0.1163 | 0.1321 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.014 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0059 | 0.1964 | 0.1964 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.014 | 0.5 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0059 | 0.1964 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.1964 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0122 | 0.6768 | 0.6768 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (functional) | = 145 uM | Dose required to reduce the viablity of mock-infected cells by 50% | ChEMBL. | 9154967 |
CC50 (functional) | = 145 uM | Dose required to reduce the viablity of mock-infected cells by 50% | ChEMBL. | 9154967 |
EC50 (functional) | > 145 uM | Dose required to achieve 50% protection of MT-4 cells from the HIV-1 induced cytopathogenicity in mock-infected MT-4 cells | ChEMBL. | 9154967 |
EC50 (functional) | > 145 uM | Dose required to achieve 50% protection of MT-4 cells from the HIV-1 induced cytopathogenicity in mock-infected MT-4 cells | ChEMBL. | 9154967 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.